NewsRx

Search our medical news database

Patents

Three Rivers Pharmaceuticals, Llc Protects Its Intellectual Property

Published in Healthcare Mergers, Acquisitions and Ventures Week, June 30th, 2007

Three Rivers Pharmaceuticals, LLC, a leading specialty drug manufacturer today announced that it has sued Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited for infringement of Three Rivers' United States Patent No. 6,720,000. The '000 patent is directed to a new and important process for producing ribavirin pellets using wet granulation. Ribavirin is a synthetic nucleoside analog with broad spectrum antiviral properties used to treat patients with Hepatitis C and other viral infections.

The lawsuit against Zydus and Cadila, now pending in the United States District Court for the Eastern District of Virginia, seeks to enjoin those defendants from making,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook